Back
Black Diamond Therapeutics Stock Price Chart
9,530x the last time this happened
Here's what our expert says you should buy before April 14.
Buy
54
BDTX
Black Diamond Therapeutics
Last Price:
5.95
Seasonality Move:
17.97%
7 Day Trial
ALL ACCESS PASS
$
7
My #1 Coin is...
All the details are on the next page.- The current trend is moderately bearish and BDTX is experiencing selling pressure, which indicates risk of future bearish movement.
Black Diamond Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.73 | Sell |
| 20-day SMA: | 5.91 | Buy |
| 50-day SMA: | 5.25 | Buy |
| 200-day SMA: | 3.59 | Buy |
| 8-day EMA: | 6.53 | Sell |
| 20-day EMA: | 6.09 | Buy |
| 50-day EMA: | 5.4 | Buy |
| 200-day EMA: | 3.97 | Buy |
Black Diamond Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 52.88 | Buy |
| Chaikin Money Flow: | -458435 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.05 - 6.53) | Buy |
| Bollinger Bands (100): | (3.22 - 5.6) | Buy |
Black Diamond Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 6.11 while BDTX 8-day simple moving average is 6.73, which is a Sell signal.
- The stock price of BDTX is 6.11 while Black Diamond Therapeutics 20-day SMA is 5.91, which makes it a Buy.
- Black Diamond Therapeutics 50-day simple moving average is 5.25 while BDTX share price is 6.11, making it a Buy technically.
- BDTX stock price is 6.11 and Black Diamond Therapeutics 200-day simple moving average is 3.59, creating a Buy signal.
BDTX Technical Analysis vs Fundamental Analysis
Buy
54
Black Diamond Therapeutics (BDTX)
is a Buy
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a Buy
The current Black Diamond Therapeutics [BDTX] share price is $6.11. The Score for BDTX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
320.96M
Price in USD:
6.11
Share Volume:
542.97K
Black Diamond Therapeutics 52-Week Range
52-Week High:
7.66
52-Week Low:
1.57
Buy
54
Black Diamond Therapeutics (BDTX)
is a Buy
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?
The Black Diamond Therapeutics stock price is 6.11 USD today. -
Will BDTX stock go up or go down?
Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Black Diamond Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is not overvalued.
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 6.11 while BDTX 8-day exponential moving average is 6.53, which is a Sell signal.
- The stock price of BDTX is 6.11 while Black Diamond Therapeutics 20-day EMA is 6.09, which makes it a Buy.
- Black Diamond Therapeutics 50-day exponential moving average is 5.40 while BDTX share price is 6.11, making it a Buy technically.
- BDTX stock price is 6.11 and Black Diamond Therapeutics 200-day simple moving average is 3.97, creating a Buy signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.16 per share, an increase this year of $0.51 per share, and a decrease next year of $0.19 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
- BDTX Moving Average Covergence Divergence (MACD) indicator is 0.46, suggesting Black Diamond Therapeutics is a Buy
- Black Diamond Therapeutics Relative Strength Index (RSI) is 52.88, which suggest Black Diamond Therapeutics is overbought
- The Bollinger Bands (25) for Black Diamond Therapeutics is (5.05 - 6.53), which suggest Black Diamond Therapeutics is a Buy
- The Bollinger Bands (100) for Black Diamond Therapeutics is (3.22 - 5.6), which suggest Black Diamond Therapeutics is a Buy
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.